Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Loan Conversion

23 Dec 2005 07:00

Embargoed Release: 07:00hrs Friday 23rd December 2005 SOPHEON PLC Conversion of loan stock Extension of Equity Line Agreement International Financial Reporting Standards Change of Auditors Sopheon plc announces that it has issued 10,197,327 ordinary shares inconnection with the maturity of its remaining balance of ‚£1,223,679 ofconvertible loan stock. The convertible loan stock is now fully converted, asforeseen in Sopheon's annual report and other announcements. The conversion hasresulted in the issue of 3,250,000 ordinary shares to Mr B K Mence, a director,changing the total holding in which Mr Mence is beneficially interested to14,423,847 ordinary shares, representing 10.8% of the Company's issued sharecapital. The conversion has also resulted in the issue of 5,416,667 ordinaryshares to Norman Nominees Limited, changing its total shareholding to 9,891,260ordinary shares, representing 7.4% of the Company's issued share capital.Application has been made for the new ordinary shares, which are subject tocertain lock-in requirements, to be admitted to trading on AIM. Dealings areexpected to commence on 3 January 2006.Sopheon is also pleased to advise that its equity line of credit facility withGEM Global Yield Fund Limited ("GEM") due to expire today has been extended fora two year period through to 23 December 2007. As part of the agreement, thecosts of the extension, as well as outstanding commitment fees relating to theinitial term, have been satisfied by the issue of 400,000 ordinary shares toGEM at a price of 18p per ordinary share. Over 90% of the original ¢â€š¬10mfacility remains available under the extended agreeement. Application has beenmade for the new ordinary shares to be admitted to trading on AIM, and dealingsare expected to commence on 3 January 2006.Although Sopheon's AIM listing provides for an exemption from the adoption ofInternational Financial Reporting Standards ("IFRS") until the financialstatements for the year 2007, the board has continued to evaluate the relativemerits of early adoption of IFRS as opposed to continued application of UKGAAP. In view of the increasing importance of the group's shareholders thattrade through Euronext, coupled with the effect of extensive changes comingthrough in UK GAAP relating to its convergence with IFRS, the board has nowconcluded in consultation with its advisers that adoption of IFRS as of the2005 financial statements is appropriate.A detailed evaluation of the effects of the adoption of IFRS on Sopheon'sfinancial statements is ongoing but the preliminary conclusions as to the keyareas likely to be materially affected are (i) an option pricing model will beused to work out the fair value of share options granted during a period, withthis value being charged to the profit and loss account over the expectedvesting period; (ii) certain research and development expenditure may becapitalised and amortised based on detailed technical criteria, rather thanautomatically charging such costs in the profit and loss account as they arise;(iii) certain short term non-trade payables and receivables may requirerestatement or reclassification and (iv) certain acquired goodwill may requirereclassification as an intangible asset. It is not expected that the treatmentand reporting of Sopheon's revenues will be affected by the adoption of IFRS.Finally, the Sopheon board wishes to announce that BDO Stoy Hayward hasreplaced Ernst & Young as auditors with immediate effect. BDO is the world'sfifth largest accountancy network. Its focus on growth oriented companiesaligns well with Sopheon's business characteristics, and will deliver a morecost effective audit service. The BDO member firms in the Netherlands and inthe USA are respectively BDO CampsObers Accountants & Belastingadviseurs, andBDO Seidman LLP. Ernst & Young remain Sopheon's tax advisers.For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 ENDSOPHEON PLC
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.